Free shipping on all orders over $ 500

Tirbanibulin (KX2-391)

Cat. No. M2313
Tirbanibulin (KX2-391) Structure
Synonym:

KX-01; tirbanibulin

Size Price Availability Quantity
5mg USD 65  USD65 In stock
10mg USD 80  USD80 In stock
50mg USD 320  USD320 In stock
100mg USD 540  USD540 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tirbanibulin (KX2-391) is a synthetic, orally bioavailable small molecule and non-ATP competitive Src tyrosine kinase signaling inhibitor with an IC50 of average 72 nM. Tirbanibulin (KX2-391) has potential antineoplastic activity. Src kinase inhibitor KX2-391 specifically binds to the peptide substrate binding site of Src kinase. In addition, Tirbanibulin (KX2-391) also inhibits microtubule polymerization. Preclinical studies have suggested that KX2-391 is able to prevent the proliferation and metastasis of prostate cancer cell lines in mouse xenografts. 

Chemical Information
Molecular Weight 431.53
Formula C26H29N3O3
CAS Number 897016-82-9
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Anna H Dlott, et al. Tirbanibulin: Topical Treatment for Actinic Keratosis

[2] No authors listed. Am J Health Syst Pharm. Tirbanibulin

[3] Anthony Markham, et al. Tirbanibulin: First Approval

[4] Andrew Blauvelt, et al. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

[5] No authors listed. Tirbanibulin

Related Src-bcr-Abl Products
Asciminib hydrochloride

Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.

Osteogenic Growth Peptide (10-14)

Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity.

Abl Cytosolic Substrate

Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ).

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH is a high-affinity pentapeptide to bind to the src SH2 domain (IC50≈1 µM).

p60c-src substrate II

p60c-src substrate II is an efficient pentapeptide substrate for the tyrosine kinase pp60c-src.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tirbanibulin (KX2-391), KX-01; tirbanibulin supplier, Src-bcr-Abl, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.